Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 9-10

  Burt, E C ^a   McGown, G ^a   Thorncroft, M ^a   James, L A ^a   Birch, J M ^b   Varley, J M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

CDKN2; Li Fraumeni syndrome; p16; p19(ARF); PTEN

Indexed keywords

ARTICLE; CELL CYCLE; FAMILIAL CANCER; GENE MUTATION; GENETIC DISORDER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LI-FRAUMENI SYNDROME; MUTATION; PEDIGREE; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0032945895     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690313     Document Type: Article

References (15)

1. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibanez-Koref MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304
2. Chen J, Lindblom P and Lindhlom A (1998) A study of the PTEN/MMACI gene in 136 breast cancer families. Hum Genet 102: 124-125
3. Foulkes WD, Flanders TY, Pollock PM and Hayward NK (1997) The CDKN2A (p16) gene and human cancer. Mol Med 3: 5-20
4. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA and Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 8: 15-21
5. Kamb A (1995) Cell-cycle regulators and cancer. TIG 11: 136-140
6. Li FP, Fraumeni JF Jr. Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358-5362
7. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943-1947
8. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FR, Tainsky MA and Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238
9. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R and Tonks NK (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057
10. INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049
11. Quelle DE, Zindy F, Ashmun RA and Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000
12. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R. Swedlund B, Teng DHF and Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15: 356-362
13. Tsou HC, Teng DH-F, Li Ping X, Brancolini V, Davis T, Hu R, Xun Xie X, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV and Peacocke M (1997) The role of MMACI mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCAI-negative cases. Am J Hum Genet 61: 1036-1043
14. Varley JM, Evans DGR and Birch JM (1997a) Li-Fraumeni syndrome: a molecular and clinical review. Br J Cancer 76: 1-14
15. Varley JM, McGown G, Thorncroft M, Santibanez Koref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997b) Germline mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245-3252